Charles began his career as a doctor in the UK, after earning degrees in medicine and in psychology having studied at Dundee, UCL and Oxford. He now works as investor and entrepreneur to develop beneficial technologies as nonprofit and for-profit enterprises –- in the healthcare space, and also in the environmental sphere. He is the author of several peer-reviewed scientific articles and patents. Primary role is as founding CEO of Loxbridge, a "venture pilot" investment company focusing on building enterprises developing innovative beneficial technologies to address massive global unmet needs.
Charles acts as CEO of many of the Loxbridge projects such as Altermune -– the brainchild of Nobel Laureate Kary Mullis (inventor of PCR and Chief Scientist) –- a company with a first-in-class drug platform against infectious diseases and cancer. Charles has also organised clinical trials with Oxford University and others to develop innovative diagnostics and medical devices, including investigation of a non-invasive, non-X-Ray and low-cost electrical impedance imaging technology with potential to revolutionise breast screening in both the developed and developing worlds.
In the environmental space, Charles is the founding CEO of greeenstar.org, a nonprofit creating a new market force to promote carbon emission reductions at large companies -– by rating them against their sector competitors on emissions performance and making ratings accessible for consumers online via Search. The greeenstar model has received widespread acclaim and interest from academic groups (at Oxford, Cambridge and Stanford Universities, the World Resources Institute) and NGOs (e.g., NRDC, Forum for the Future, WWF) as well as powering the research for the Gigaton Awards at Durban 2012 for Carbon War Room, Richard Branson’s nonprofit. The project was presented at TED U Long Beach in March 2011 to an audience including Bill Gates and other luminaries.
Charles has also pursued a recreational love for photography and film, leading to commissioned work for national papers such as Scotland on Sunday and Sunday Herald shot whilst a medical student, and volunteer work directing short films for health care charities. The film Satchin -- The Deadly Push (for Safepoint Trust and Save the Children), highlighting the dangers of needle re-use, won a Highly Commended in the IVCA Clarion Awards, has been praised by the President of India, and won €1Million philanthropic foundation funding for distribution. In November 2008 it was screened to cinema and television audiences totalling a record 208 million people, making it the largest public information broadcast in India’s history.
Charlie enjoys rare moments of painting and writing (though lost his Twitter virginity very recently), and the toils of trying to learn piano as an adult.